Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
23.15
-0.37 (-1.57%)
At close: Jun 27, 2025, 4:00 PM
24.07
+0.92 (3.97%)
After-hours: Jun 27, 2025, 7:30 PM EDT
Janux Therapeutics Employees
Janux Therapeutics had 81 employees as of December 31, 2024. The number of employees increased by 17 or 26.56% compared to the previous year.
Employees
81
Change (1Y)
17
Growth (1Y)
26.56%
Revenue / Employee
$115,259
Profits / Employee
-$959,778
Market Cap
1.37B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 81 | 17 | 26.56% |
| Dec 31, 2023 | 64 | 4 | 6.67% |
| Dec 31, 2022 | 60 | 27 | 81.82% |
| Dec 31, 2021 | 33 | 21 | 175.00% |
| Dec 31, 2020 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
JANX News
- 6 weeks ago - Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer - Business Wire
- 7 weeks ago - Janux Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights - Business Wire
- 7 weeks ago - Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates - Business Wire
- 3 months ago - Janux Therapeutics: Buying For The Promising Pipeline, Holding For The Buyout - Seeking Alpha
- 4 months ago - Janux Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - Business Wire
- 5 months ago - Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer - Business Wire
- 6 months ago - Janux Therapeutics: mCRPC TAM And Promising JANX007's Phase 1 Data - Seeking Alpha
- 6 months ago - Best-Performing Stocks Of 2024 - Seeking Alpha